- Home
- ORGO vs CTLP Comparison
ORGO vs CTLP Comparison
Compare ORGO & CTLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- CTLP
- Stock Information
- Founded
- ORGO 1985
- CTLP 1992
- Country
- ORGO United States
- CTLP United States
- Employees
- ORGO N/A
- CTLP N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- CTLP EDP Services
- Sector
- ORGO Health Care
- CTLP Technology
- Exchange
- ORGO Nasdaq
- CTLP Nasdaq
- Market Cap
- ORGO 665.8M
- CTLP 574.8M
- IPO Year
- ORGO N/A
- CTLP N/A
- Fundamental
- Price
- ORGO $4.28
- CTLP $7.73
- Analyst Decision
- ORGO Buy
- CTLP Strong Buy
- Analyst Count
- ORGO 2
- CTLP 4
- Target Price
- ORGO $5.50
- CTLP $12.50
- AVG Volume (30 Days)
- ORGO 1.3M
- CTLP 464.0K
- Earning Date
- ORGO 05-08-2025
- CTLP 05-08-2025
- Dividend Yield
- ORGO N/A
- CTLP N/A
- EPS Growth
- ORGO N/A
- CTLP N/A
- EPS
- ORGO N/A
- CTLP 0.19
- Revenue
- ORGO $482,043,000.00
- CTLP $285,112,000.00
- Revenue This Year
- ORGO N/A
- CTLP $18.00
- Revenue Next Year
- ORGO $7.62
- CTLP $15.55
- P/E Ratio
- ORGO N/A
- CTLP $41.40
- Revenue Growth
- ORGO 11.29
- CTLP 12.88
- 52 Week Low
- ORGO $2.17
- CTLP $5.75
- 52 Week High
- ORGO $6.71
- CTLP $11.36
- Technical
- Relative Strength Index (RSI)
- ORGO 43.72
- CTLP 38.07
- Support Level
- ORGO $4.80
- CTLP $7.31
- Resistance Level
- ORGO $5.57
- CTLP $8.08
- Average True Range (ATR)
- ORGO 0.32
- CTLP 0.33
- MACD
- ORGO -0.15
- CTLP 0.03
- Stochastic Oscillator
- ORGO 3.73
- CTLP 46.15
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About CTLP Cantaloupe Inc.
Cantaloupe Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Cashless devices, eSuds, EnergyMisers, and Value-added services which include Loyalty and Prepaid, Intelligent Vending, and others. The company offers services to different industries covering car wash, taxi and transportation, laundry, vending, kiosk, amusement, and arcade. The company derives revenue from the sale or lease of equipment and services to the small ticket, unattended POS market, and the majority of its revenue is derived from subscription and transaction fees.